The Oral Health Pro with CancerDetect uses artificial intelligence and proprietary RNA sequencing technology. It has a 95 percent specificity rate and a 90 percent sensitivity rate, making it the most advanced oral and throat cancer screening test available, according to a Sept. 28 news release.
In addition to detecting oral and throat cancer, the test also detects biomarkers associated with other oral health conditions, including poor gum health, cavities and fungal activity.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
